Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors

Clinical trial NCT03627403 · TERMINATED

Trial details

NCT number: NCT03627403
Sponsor: University of Utah
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Post-polycythemia Vera Myelofibrosis

Start date: 2019-05-10
Primary completion: 2023-08-16
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.